Quick answers
- What is Namzaric?
- Namzaric is a brand name of Memantine and donepezil, a prescription medicine. The FDA NDC Directory lists 4 Namzaric products in 4 strengths and forms.
- Who makes Namzaric?
- Abbvie holds the FDA application for Namzaric (NDA206439, approved December 23, 2014).
- Is there a generic or store brand of Namzaric?
- Other products of Memantine and donepezil are listed with the FDA, but none in exactly the same strength and form as a Namzaric product.
- What do pharmacies pay for Namzaric?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 4 Namzaric strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Namzaric been recalled?
- FDA enforcement reports list 1 recall of Namzaric products; the newest started March 15, 2021. A recall usually concerns specific lots, not every product.
What Namzaric is
Each Namzaric product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Memantine and donepezil · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| donepezil hydrochloride 10 mg · memantine hydrochloride 14 mg capsule (oral) | Namzaric | None listed | DailyMed |
| donepezil hydrochloride 10 mg · memantine hydrochloride 21 mg capsule (oral) | Namzaric | None listed | DailyMed |
| donepezil hydrochloride 10 mg · memantine hydrochloride 28 mg capsule (oral) | Namzaric | None listed | DailyMed |
| donepezil hydrochloride 10 mg · memantine hydrochloride 7 mg capsule (oral) | Namzaric | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Memantine and donepezil →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA206439 | Abbvie | December 23, 2014 | 4 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| donepezil hydrochloride 10 mg · memantine hydrochloride 14 mg capsule | Brand: Namzaric | $19.88 per capsule |
| donepezil hydrochloride 10 mg · memantine hydrochloride 21 mg capsule | Brand: Namzaric | $19.92 per capsule |
| donepezil hydrochloride 10 mg · memantine hydrochloride 28 mg capsule | Brand: Namzaric | $19.80 per capsule |
| donepezil hydrochloride 10 mg · memantine hydrochloride 7 mg capsule | Brand: Namzaric | $19.85 per capsule |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Namzaric
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Namzaric products.
- Allergan, Inc.4 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 15, 2021 · Class II · Terminated · D-0418-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Namzaric (memantine HCl extended release and donepezil HCl) capsules 14 mg/10 mg per capsule 30 capsules Rx Only NDC 0456-1214-30 Distributed by Forest Pharmaceuticals, Inc. Subsidiary of Forest Laboratories, LLC. — Cardinal Health Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.